HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Clinical trials for HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: Rina-S faces off against chemo in major trial
Disease control Not yet recruitingThis large Phase 3 trial will test a new drug called Rina-S, alone or with bevacizumab, against standard platinum-based chemotherapy for women with ovarian cancer that has returned after initial treatment. About 688 participants will be randomly assigned to receive either the new…
Matched conditions: HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New targeted drug shows promise for Hard-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study tests a new drug called BRY812 in people with advanced ovarian, endometrial, or ovarian clear cell cancers that have a specific marker (LIV-1). The goal is to see if the drug can shrink tumors and how safe it is. About 56 participants will receive the drug, and researc…
Matched conditions: HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC